NRARP (NOTCH regulated ankyrin repeat protein) functions as a downstream effector and negative regulator of Notch signaling 1. The gene is directly regulated by Notch through Su(H)-dependent transcription factor binding sites, establishing a negative feedback loop that prevents excessive Notch signal expansion 1. NRARP integrates Notch and Wnt signaling pathways, acting as a molecular link between these critical developmental pathways 2. In vascular biology, NRARP regulates endothelial cell proliferation during angiogenesis by coordinating Notch and Wnt signals at vascular branch points 3. Clinically, NRARP dysregulation contributes to multiple cancer types. In breast cancer, NRARP is commonly overexpressed and promotes cell proliferation through Wnt/β-catenin signaling; its silencing inhibits cell growth and induces senescence 425. Similarly, NRARP downregulation exerts antitumor effects in thyroid cancer by inducing G1 arrest and apoptosis 6. In reninoma, NOTCH1 rearrangements that remove NRARP result in excessive Notch signaling, representing a targetable disease mechanism 3. In T-cell acute lymphoblastic leukemia, NRARP displays context-dependent roles, suppressing Notch-driven proliferation but promoting Wnt-dependent expansion in cells with low Notch activity 7. These findings suggest NRARP as a potential therapeutic target across multiple malignancies.